Article
ELABELA as a Potential Diagnostic Biomarker and Therapeutic Target of Atherosclerosis
2024-11-08
Abstract excerpt
Atherosclerosis (AS) is a progressive arterial disease characterized by chronic inflammation and plaque formation in blood vessel walls. ELABELA, an endogenous ligand for the G protein-coupled receptor APJ (apelin peptide jejunum, apelin receptor), has multiple pharmacological activities for protecting the cardiovascular system. This study aimed to determine the potential anti-atherosclerotic effect of ELABELA and...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- f7ac465c-42ac-5230-b74c-5d24bebb3e9e
- DOI
- 10.1101/2024.11.07.24316940
